Authors: Varella-Garcia, M Hogan, CJ Odom, LF Murata-Collins, JL Ai, H Chen, L Richkind, K Paskulin, C Andreeff, M Brizard, A McGavran, L Gemmill, RM Berger, R Drabkin, HA

Citation: M. Varella-garcia et al., Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34(+) cell sorting, LEUKEMIA, 15(9), 2001, pp. 1408-1414

Authors: Koyle, MA Hatch, DA Furness, PD Lovell, MA Odom, LF Kurzrock, EA

Citation: Ma. Koyle et al., Long-term urological complications in survivors younger than 15 months of advanced stage abdominal neuroblastoma, J UROL, 166(4), 2001, pp. 1455-1458

Authors: Meech, SJ McGavran, L Odom, LF Lang, XY Meltesen, L Gump, J Wei, Q Carlsen, S Hunger, SP

Citation: Sj. Meech et al., Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4-anaplastic lymphoma kinase gene fusion, BLOOD, 98(4), 2001, pp. 1209-1216

Authors: Maloney, KW McGavran, L Murphy, JR Odom, LF Stork, L Wei, Q Hunger, SP

Citation: Kw. Maloney et al., TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification, LEUKEMIA, 13(11), 1999, pp. 1708-1712

Authors: Maloney, KW McGavran, L Odom, LF Hunger, SP

Citation: Kw. Maloney et al., Acquisition of p16(INK4A) and p15(INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia, BLOOD, 93(7), 1999, pp. 2380-2385